SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-20-029574
Filing Date
2020-10-28
Accepted
2020-10-28 20:48:58
Documents
2
Period of Report
2020-10-28

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2951
2 EX-24 DOCUMENT attachment1.htm EX-24 4751
  Complete submission text file 0000899243-20-029574.txt   9115
Mailing Address C/O SPRING BANK PHARMACEUTICALS, INC. 113 CEDAR STREET, STE S-7 MILFORD MA 01757
Business Address
Freve Jonathan (Reporting) CIK: 0001664466 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39655 | Film No.: 201270177

Mailing Address GALECTO BIOTECH AB OLE MAALOES VEJ3 COPENHAGEN G7 DK-2200
Business Address GALECTO BIOTECH AB OLE MAALOES VEJ3 COPENHAGEN G7 DK-2200 45-70-70-52-10
Galecto Inc. (Issuer) CIK: 0001800315 (see all company filings)

IRS No.: 371957007 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences